Cathy Zhao

Head‐to‐head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study

Michael E. Weinblatt, Michael Schiff, R. Valente et al. · Arthritis & Rheumatism · 2012 · 244 citations · Full text

Rheumatology 20, Rheumatology, Active Ra +15

TLR4 Activation Promotes Podocyte Injury and Interstitial Fibrosis in Diabetic Nephropathy

Jin Ma, Steven J. Chadban, Cathy Zhao et al. · PLoS ONE · 2014 · 149 citations · Full text

Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)

Joanne R Chalmers, Eric L. Simpson, Christian Apfelbacher et al. · British Journal of Dermatology · 2016 · 124 citations · Full text

OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled study

Jon M. Hanifin, Charles N. Ellis, Ilona J. Frieden et al. · Journal of the American Academy of Dermatology · 2016 · 104 citations · Full text

Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers

Sujata Vaidyanathan, Jessica Valencia, Charisse Kemp et al. · International Journal of Clinical Practice · 2006 · 87 citations